Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Total Debt (2016 - 2025)

Surgery Partners' Total Debt history spans 12 years, with the latest figure at $3.7 billion for Q4 2025.

  • For Q4 2025, Total Debt rose 9.85% year-over-year to $3.7 billion; the TTM value through Dec 2025 reached $3.7 billion, up 9.85%, while the annual FY2025 figure was $3.7 billion, 9.85% up from the prior year.
  • Total Debt for Q4 2025 was $3.7 billion at Surgery Partners, up from $3.6 billion in the prior quarter.
  • Across five years, Total Debt topped out at $3.7 billion in Q4 2025 and bottomed at $2.6 billion in Q2 2023.
  • The 5-year median for Total Debt is $3.0 billion (2021), against an average of $3.1 billion.
  • The largest annual shift saw Total Debt fell 16.78% in 2023 before it rose 23.68% in 2025.
  • A 5-year view of Total Debt shows it stood at $2.9 billion in 2021, then fell by 10.79% to $2.6 billion in 2022, then rose by 5.85% to $2.8 billion in 2023, then increased by 21.45% to $3.4 billion in 2024, then increased by 9.85% to $3.7 billion in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Total Debt are $3.7 billion (Q4 2025), $3.6 billion (Q3 2025), and $3.6 billion (Q2 2025).